- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01819324
A Lifestyle Intervention for Breast Cancer Survivors (TTMI)
Targeting the Teachable Moment: A Lifestyle Intervention for Breast Cancer Survivors
- The purpose of the study is to test the effectiveness of a new mail-based intervention for breast cancer survivors compared with standard lifestyle management and no-treatment.
- This intervention addresses both lifestyle factors such as dietary and physical activities and psychological issues specific to breast cancer survivors to improve healthy behaviors.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be assigned randomly to one of three groups: 1) newly developed mail-based intervention (Targeting the Teachable Moment Intervention; TTMI), 2) standard Lifestyle Intervention (SLM), and 3) usual care. Both TTMI and SLM focus on health behaviors, however TTMI additionally addresses psychosocial issues specific to breast cancer survivors.
All participants will complete questionnaires at the time they start the study, the end of the 4 months, and 3 months later for a follow-up.
If participants are assigned to any of the intervention group, they will receive materials every other week for 4 months. If participants are assigned to the usual care group, they will receive the same materials as the standard lifestyle intervention et the end of the 7 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Storrs, Connecticut, United States, 06269
- University of Connecticut
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- First diagnosed with breast cancer in the past 1.5 years
- stage 0~2 breast cancer
- no prior adjuvant treatment for another cancer
- Can read and write English
- Are not participating in other health behavior research right now
Exclusion Criteria:
- apparent serious mental disturbance
- male breast cancer survivors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Targeting the Teachable Moment
Receiving Targeting the Teachable Moment Intervention materials (focusing on health behaviors and issues specific to breast cancer survivors) every other week for 4 months
|
TTMI material (every other week for 4 months)
Other Names:
|
|
Active Comparator: Standardized Lifestyle Management
Receiving Standardized Lifestyle Management materials (focusing mostly on health behaviors) every other week for 4 months
|
SLM material (every other week for 4 months)
Other Names:
|
|
No Intervention: Usual Care
Receiving SLM materials at the end of the 7 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in eating habits measured by the National Cancer Institute Quick Food Scan
Time Frame: Meaured at baseline, 4 months, and 7 months
|
Diet habits (amount of fat and fruit/vegetable uptake) will be assessed at 3 times: at baseline, at the end of the 4 months, and at the end of 7 months.
|
Meaured at baseline, 4 months, and 7 months
|
|
Changes in physical activity measured by the Paffenbarger physical activity questionnaire
Time Frame: Meaured at baseline, 4 months, and 7 months
|
Frequency and amount of time for physical exercise will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months.
|
Meaured at baseline, 4 months, and 7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in coping strategies measured by the Brief COPE
Time Frame: Measured at baseline, 4 months, and 7 months
|
Coping strategies (e.g., problem-focused coping, emotional approach coping) will be assessed at 3 times: at baseline, at the end of the 4 months, and at the end of 7 months.
|
Measured at baseline, 4 months, and 7 months
|
|
Changes in Self-efficacy measured by the General Self-Efficacy Scale
Time Frame: Measured at baseline, 4 months, and 7 months
|
A general sense of perceived self-efficacy will be measured at 3 times: at the baseline, at the end of 4 months, and at the end of 7 months
|
Measured at baseline, 4 months, and 7 months
|
|
Changes in social support measured by the Interpersonal Support Evaluation List (ISEL)
Time Frame: Measured at baseline, 4 months, and 7 months
|
Social support will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months
|
Measured at baseline, 4 months, and 7 months
|
|
Changes in life meaning measured by the Meaning in Life Questionnaire (MLQ)
Time Frame: Measured at baseline, 4 months, and 7 months
|
Presence of Meaning and Search for Meaning will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months.
|
Measured at baseline, 4 months, and 7 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feedback of each module
Time Frame: up to 4 months
|
usefulness of each module (e.g., whether each intervention is helpful or not) will be assessed at each mailing (for eight times) for 4 months.
|
up to 4 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Crystal L. Park, Ph.D, University of Connecticut
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Park003382HE
- 5R21CA152129-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
Clinical Trials on Targeting the Teachable Moment
-
Case Western Reserve UniversityCompletedSmoking Cessation | Weight Management | Clinician Patient CommunicationUnited States
-
Louisville VA Medical CenterUniversity of LouisvilleCompletedSuicide, AttemptedUnited States
-
Case Western Reserve UniversityPatient-Centered Outcomes Research InstituteCompletedSmoking | Tobacco Dependence
-
Western Kentucky UniversityVanderbilt UniversityCompletedSuicide AttemptUnited States
-
University of TulsaTerminatedSuicide, AttemptedUnited States
-
Florida International UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
DanceStream ProjectsAlzheimer's AssociationRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Lewy Body Disease | Frontotemporal Dementia | Vascular DementiaUnited States
-
Université de MontréalCanadian Institutes of Health Research (CIHR)Completed
-
Renmin Hospital of Wuhan UniversityYichang Central People's Hospital; Wuhan Central Hospital; Xiangyang Central... and other collaboratorsNot yet recruitingDiagnosed With Cardiovascular Diseases and Scheduled to Undergo Interventional Cardiology ProceduresChina
-
Timothy YuRecruitingAtaxia TelangiectasiaUnited States